22 Recruiting Studies Using Capivasertib

Active clinical trials that use this intervention, sourced directly from the NIH registry.

Browse by condition

Trials Using Capivasertib

🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama

Endometrial Adenocarcinoma

View Study & Checklist ➔